Unfavorable Response to Capmatinib for MET Exon14 Skipping after First-Line Osimertinib in a Patient with EGFR-mutated Lung Adenocarcinoma: A Case Report and Literature Review
Respiratory Investigation（2024）
Key words
exon14 skipping,Osimertinib,Capmatinib,Resistance,MET
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined